{"lead_paragraph": "The insulin, called Afrezza, has had poor sales since being approved by the F.D.A. in 2014. Shares in its maker, MannKind, fell 48 percent.", "pub_date": "2016-01-06T00:00:00Z", "slideshow_credits": null, "byline": {"person": [{"lastname": "POLLACK", "role": "reported", "rank": 1, "organization": "", "firstname": "Andrew"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "section_name": "Business Day", "snippet": "The insulin, called Afrezza, has had poor sales since being approved by the F.D.A. in 2014. Shares in its maker, MannKind, fell 48 percent.", "multimedia": [{"subtype": "wide", "width": 190, "height": 126, "type": "image", "url": "images/2016/01/06/business/06Insulin/06Insulin-thumbWide.jpg", "legacy": {"wide": "images/2016/01/06/business/06Insulin/06Insulin-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}}, {"subtype": "xlarge", "width": 600, "height": 400, "type": "image", "url": "images/2016/01/06/business/06Insulin/06Insulin-articleLarge.jpg", "legacy": {"xlargeheight": "400", "xlarge": "images/2016/01/06/business/06Insulin/06Insulin-articleLarge.jpg", "xlargewidth": "600"}}, {"subtype": "thumbnail", "width": 75, "height": 75, "type": "image", "url": "images/2016/01/06/business/06Insulin/06Insulin-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2016/01/06/business/06Insulin/06Insulin-thumbStandard-v2.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}}], "blog": [], "type_of_material": "News", "headline": {"main": "Sanofi Ends Marketing Deal With Developer of Inhaled Insulin", "print_headline": "Shares of Inhaled Insulin Maker Plummet 48% as Big Marketing Partner Pulls Out"}, "keywords": [{"rank": "1", "name": "organizations", "is_major": "Y", "value": "Sanofi SA"}, {"rank": "2", "name": "organizations", "is_major": "Y", "value": "MannKind Corporation"}, {"rank": "3", "name": "persons", "is_major": "N", "value": "Mann, Alfred E"}, {"rank": "4", "name": "organizations", "is_major": "N", "value": "Pfizer Inc"}, {"rank": "5", "name": "organizations", "is_major": "N", "value": "Food and Drug Administration"}, {"rank": "6", "name": "subject", "is_major": "N", "value": "Diabetes"}], "web_url": "http://www.nytimes.com/2016/01/06/business/sanofi-ends-marketing-deal-with-developer-of-inhaled-insulin.html", "print_page": "2", "source": "The New York Times", "news_desk": "Business", "abstract": "Insulin developer MannKind announces that Sanofi is ending agreement in which it had rights to market inhaled insulin called Afrezza; drug has not met sales expectations since Food and Drug Administration approval.", "word_count": "914", "_id": "568c05fb38f0d803f4a0c464", "subsection_name": null}